SANTA CLARA, Calif.--(BUSINESS WIRE)--The National Cancer Institute (NCI) today announced grant recipients for its coveted Cancer Genome Atlas pilot project, including three institutions using microarray platforms from Agilent Technologies Inc. (NYSE:A): the University of North Carolina, Dana-Farber Cancer Institute and Memorial Sloan-Kettering Cancer Center.
